We are live on ! Find out more
IMUX icon

Immunic
IMUX

53 hedge funds and large institutions have $44.8M invested in Immunic in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more call options, than puts

Call options by funds: $100K | Put options by funds: $16K

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

20% more capital invested

Capital invested by funds: $37.5M → $44.8M (+$7.39M)

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0% more ownership

Funds ownership: 0.07% → 0.07% (+0%)

4% less funds holding

Funds holding: 55 → 53 (-2)

Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
15
Reduced
14
Closed
5
Calls
$100K
Puts
$16K
Net Calls
+$84K
Net Calls Change
-$35K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.86M
2
BlackRock
BlackRock
New York
+$6.22M
3
AG
Artal Group
Luxembourg
+$4.01M
4
Victory Capital Management
Victory Capital Management
Texas
+$1.02M
5
UOC
UBS O'Connor
Illinois
+$915K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$458K
2
AFM
Anson Funds Management
Texas
-$270K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$210K
4
Morgan Stanley
Morgan Stanley
New York
-$172K
5
ARTA
A.R.T. Advisors
New York
-$66K

IMUX Hedge Fund Activity: Q1 2017 in Review

53 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2017, worth a combined $44.8M — up 20% from $37.5M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMUX positions and 5 closed out — a net gain of 2 holders — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $6.86M. The largest seller was Millennium Management, cutting an estimated $458K.

  • 53 institutional investors held Immunic (IMUX) as of Q1 2017, down from 55 in Q4 2016.
  • Funds reported $44.8M of Immunic stock for Q1 2017, up 20% quarter-over-quarter.
  • 7 funds opened new Immunic positions in Q1 2017 and 5 closed out, a net change of +2 holders.
  • The largest Immunic buyer in Q1 2017 was Fidelity Investments, an estimated $6.86M added.
  • The largest Immunic seller in Q1 2017 was Millennium Management, an estimated $458K sold.

Based on aggregated 13F filings for Q1 2017.